Cargando…

COMMD10 inhibits tumor progression and induces apoptosis by blocking NF‐κB signal and values up BCLC staging in predicting overall survival in hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is the third leading cause of cancer mortality worldwide. Currently, there is limited knowledge of dysregulation of cellular proliferation and apoptosis that contribute to the malignant phenotype in HCC. Copper metabolism gene MURR1 domain 10 (COMMD10) is i...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Mi, Wu, Xixi, Li, Lu, Li, Shaoqun, Li, Nan, Mao, Mengyuan, Pan, Suming, Du, Richang, Wang, Xiaoqing, Chen, Min, Xiao, Nanjie, Zhu, Xiaohui, He, Guoyang, Zhang, Longshan, Huang, Weiqiang, Pan, Hua, Deng, Lan, Chen, Longhua, Liang, Li, Guan, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093973/
https://www.ncbi.nlm.nih.gov/pubmed/34047468
http://dx.doi.org/10.1002/ctm2.403
_version_ 1783687926508421120
author Yang, Mi
Wu, Xixi
Li, Lu
Li, Shaoqun
Li, Nan
Mao, Mengyuan
Pan, Suming
Du, Richang
Wang, Xiaoqing
Chen, Min
Xiao, Nanjie
Zhu, Xiaohui
He, Guoyang
Zhang, Longshan
Huang, Weiqiang
Pan, Hua
Deng, Lan
Chen, Longhua
Liang, Li
Guan, Jian
author_facet Yang, Mi
Wu, Xixi
Li, Lu
Li, Shaoqun
Li, Nan
Mao, Mengyuan
Pan, Suming
Du, Richang
Wang, Xiaoqing
Chen, Min
Xiao, Nanjie
Zhu, Xiaohui
He, Guoyang
Zhang, Longshan
Huang, Weiqiang
Pan, Hua
Deng, Lan
Chen, Longhua
Liang, Li
Guan, Jian
author_sort Yang, Mi
collection PubMed
description BACKGROUND: Hepatocellular carcinoma (HCC) is the third leading cause of cancer mortality worldwide. Currently, there is limited knowledge of dysregulation of cellular proliferation and apoptosis that contribute to the malignant phenotype in HCC. Copper metabolism gene MURR1 domain 10 (COMMD10) is initially identified as a suppressor gene in the pathogenesis of HCC in our observations. Here we aimed to explore its function and prognostic value in the progression of HCC. METHODS: Functional experiments were performed to explore the role of COMMD10 in HCC. The molecular mechanisms of COMMD10 were determined by luciferase assay, immunofluorescence, and immunoprecipitation. The nomogram was based on a retrospective and multicenter study of 516 patients who were pathologically diagnosed with HCC from three Chinese hospitals. The predictive accuracy and discriminative ability of the nomogram were determined by a C‐index and calibration curve and were compared with COMMD10 and the Barcelona Clinic Liver Cancer (BCLC) staging system. The primary endpoint was overall survival (OS). RESULTS: COMMD10 expression was significantly lower in HCC than that in normal liver tissues. In vitro and in vivo experiments revealed that COMMD10 suppressed cell proliferation and induced apoptosis in HCC. Mechanistically, COMMD10 inhibits TNFα mediated ubiquitination of IκBα and p65 nuclear translocation through the combination of COMMD10‐N terminal to the Rel homology domain of p65, which inhibited NF‐κB activity and increased expression of cleaved caspase9/3 in HCC. Clinically, COMMD10 stratifies early‐stage HCC patients into two risk groups with significantly different OS. Additionally, the nomogram based on COMMD10 and BCLC stage yielded more accuracy than BCLC stage alone for predicting OS of HCC patients in three cohorts. CONCLUSIONS: COMMD10 suppresses proliferation and promotes apoptosis by inhibiting NF‐κB signaling and values up BCLC staging in predicting OS, which provides evidence for the identification of potential therapeutic targets and the accurate prediction of prognosis for patients with HCC.
format Online
Article
Text
id pubmed-8093973
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-80939732021-05-10 COMMD10 inhibits tumor progression and induces apoptosis by blocking NF‐κB signal and values up BCLC staging in predicting overall survival in hepatocellular carcinoma Yang, Mi Wu, Xixi Li, Lu Li, Shaoqun Li, Nan Mao, Mengyuan Pan, Suming Du, Richang Wang, Xiaoqing Chen, Min Xiao, Nanjie Zhu, Xiaohui He, Guoyang Zhang, Longshan Huang, Weiqiang Pan, Hua Deng, Lan Chen, Longhua Liang, Li Guan, Jian Clin Transl Med Research Articles BACKGROUND: Hepatocellular carcinoma (HCC) is the third leading cause of cancer mortality worldwide. Currently, there is limited knowledge of dysregulation of cellular proliferation and apoptosis that contribute to the malignant phenotype in HCC. Copper metabolism gene MURR1 domain 10 (COMMD10) is initially identified as a suppressor gene in the pathogenesis of HCC in our observations. Here we aimed to explore its function and prognostic value in the progression of HCC. METHODS: Functional experiments were performed to explore the role of COMMD10 in HCC. The molecular mechanisms of COMMD10 were determined by luciferase assay, immunofluorescence, and immunoprecipitation. The nomogram was based on a retrospective and multicenter study of 516 patients who were pathologically diagnosed with HCC from three Chinese hospitals. The predictive accuracy and discriminative ability of the nomogram were determined by a C‐index and calibration curve and were compared with COMMD10 and the Barcelona Clinic Liver Cancer (BCLC) staging system. The primary endpoint was overall survival (OS). RESULTS: COMMD10 expression was significantly lower in HCC than that in normal liver tissues. In vitro and in vivo experiments revealed that COMMD10 suppressed cell proliferation and induced apoptosis in HCC. Mechanistically, COMMD10 inhibits TNFα mediated ubiquitination of IκBα and p65 nuclear translocation through the combination of COMMD10‐N terminal to the Rel homology domain of p65, which inhibited NF‐κB activity and increased expression of cleaved caspase9/3 in HCC. Clinically, COMMD10 stratifies early‐stage HCC patients into two risk groups with significantly different OS. Additionally, the nomogram based on COMMD10 and BCLC stage yielded more accuracy than BCLC stage alone for predicting OS of HCC patients in three cohorts. CONCLUSIONS: COMMD10 suppresses proliferation and promotes apoptosis by inhibiting NF‐κB signaling and values up BCLC staging in predicting OS, which provides evidence for the identification of potential therapeutic targets and the accurate prediction of prognosis for patients with HCC. John Wiley and Sons Inc. 2021-05-04 /pmc/articles/PMC8093973/ /pubmed/34047468 http://dx.doi.org/10.1002/ctm2.403 Text en © 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Yang, Mi
Wu, Xixi
Li, Lu
Li, Shaoqun
Li, Nan
Mao, Mengyuan
Pan, Suming
Du, Richang
Wang, Xiaoqing
Chen, Min
Xiao, Nanjie
Zhu, Xiaohui
He, Guoyang
Zhang, Longshan
Huang, Weiqiang
Pan, Hua
Deng, Lan
Chen, Longhua
Liang, Li
Guan, Jian
COMMD10 inhibits tumor progression and induces apoptosis by blocking NF‐κB signal and values up BCLC staging in predicting overall survival in hepatocellular carcinoma
title COMMD10 inhibits tumor progression and induces apoptosis by blocking NF‐κB signal and values up BCLC staging in predicting overall survival in hepatocellular carcinoma
title_full COMMD10 inhibits tumor progression and induces apoptosis by blocking NF‐κB signal and values up BCLC staging in predicting overall survival in hepatocellular carcinoma
title_fullStr COMMD10 inhibits tumor progression and induces apoptosis by blocking NF‐κB signal and values up BCLC staging in predicting overall survival in hepatocellular carcinoma
title_full_unstemmed COMMD10 inhibits tumor progression and induces apoptosis by blocking NF‐κB signal and values up BCLC staging in predicting overall survival in hepatocellular carcinoma
title_short COMMD10 inhibits tumor progression and induces apoptosis by blocking NF‐κB signal and values up BCLC staging in predicting overall survival in hepatocellular carcinoma
title_sort commd10 inhibits tumor progression and induces apoptosis by blocking nf‐κb signal and values up bclc staging in predicting overall survival in hepatocellular carcinoma
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093973/
https://www.ncbi.nlm.nih.gov/pubmed/34047468
http://dx.doi.org/10.1002/ctm2.403
work_keys_str_mv AT yangmi commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma
AT wuxixi commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma
AT lilu commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma
AT lishaoqun commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma
AT linan commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma
AT maomengyuan commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma
AT pansuming commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma
AT durichang commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma
AT wangxiaoqing commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma
AT chenmin commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma
AT xiaonanjie commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma
AT zhuxiaohui commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma
AT heguoyang commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma
AT zhanglongshan commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma
AT huangweiqiang commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma
AT panhua commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma
AT denglan commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma
AT chenlonghua commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma
AT liangli commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma
AT guanjian commd10inhibitstumorprogressionandinducesapoptosisbyblockingnfkbsignalandvaluesupbclcstaginginpredictingoverallsurvivalinhepatocellularcarcinoma